Cancer Research Campaign Adjuvant Breast Trial for patients under 50.
The objectives of the Cancer Research Campaign Adjuvant Breast Trial are to determine whether the administration of a course of adjuvant tamoxifen, or ablation of ovarian function, results in a prolongation of time to recurrence or death, for women aged under 50 years and treated for operable breast cancer. The basis and aims of the trial are discussed.
Baum
M
M
CRC Adjuvant Breast Working Party, King's College School of Medicine and Dentistry, Rayne Institute, London, UK.
Houghton
J
J
Riley
D L
DL
Melhuish
P B
PB
D000328:Adult; D001943:Breast Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010052:Ovariectomy; D013629:Tamoxifen / Q000627:therapeutic use*
D013629:Tamoxifen